Snowball logo
logo
  • Stocks
  • China
  • Materials
6050

Shaanxi Meibang Pharmaceutical Group Co Ltd

605033 • SHG
¥18.85-¥0.05  (0.26%)
Estimate
P/E
40.1
EPS
0.47
Beta
0.414
Growth
Revenue, YoY
11.58%
Net income, YoY
149.76%
FCF, YoY
-33.99%
Dividends
Dividend yield
1.06%
Annual payout
¥0.20
Next ex. div date
December 17, 26
Payout
38.59%
Div.rating
About the company
Ticker
605033
ISIN
CNE100005071
Country
China
Sector (GICS)
Materials
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, plant nutrients, fungicides, insecticides, acaricides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricultural machinery. The company was founded in 1998 and is headquartered in Xi'an, China.

Frequently asked questions

What sector does Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) operate in?

Shaanxi Meibang Pharmaceutical Group Co Ltd belongs to the Materials sector and operates in the Agricultural Inputs industry.

What is Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) current stock price?

As of the latest data, Shaanxi Meibang Pharmaceutical Group Co Ltd stock price is CN¥18.85, with a previous close of CN¥18.90. Shaanxi Meibang Pharmaceutical Group Co Ltd lost -CN¥0.05 in the last trading session, representing a -0.26% loss.

What is Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) current market capitalization?

Shaanxi Meibang Pharmaceutical Group Co Ltd market cap is approximately 2.55 billion.

What is Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.47.

What is Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) Price-to-Earnings (P/E) ratio?

Shaanxi Meibang Pharmaceutical Group Co Ltd current P/E ratio is 40.11.

Does Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) pay dividends?

Yes. Shaanxi Meibang Pharmaceutical Group Co Ltd pays semiannual dividends with an annualized yield of 1.06% and an estimated annual payout of CN¥0.20 per share.

When is the next ex-dividend date for Shaanxi Meibang Pharmaceutical Group Co Ltd (605033)?

The next ex-dividend date is scheduled for December 17, 2026.

What is Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) beta (volatility) score?

Shaanxi Meibang Pharmaceutical Group Co Ltd has a beta of 0.414, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductFor BusinessPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsSnowball Analytics MCPPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.